AU2984095A - Novel combination product comprising capripramine and a neuroleptic - Google Patents

Novel combination product comprising capripramine and a neuroleptic

Info

Publication number
AU2984095A
AU2984095A AU29840/95A AU2984095A AU2984095A AU 2984095 A AU2984095 A AU 2984095A AU 29840/95 A AU29840/95 A AU 29840/95A AU 2984095 A AU2984095 A AU 2984095A AU 2984095 A AU2984095 A AU 2984095A
Authority
AU
Australia
Prior art keywords
capripramine
neuroleptic
novel combination
combination product
novel
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU29840/95A
Inventor
Sauveur Ferrara
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pierre Fabre Medicament SA
Original Assignee
Pierre Fabre Medicament SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pierre Fabre Medicament SA filed Critical Pierre Fabre Medicament SA
Publication of AU2984095A publication Critical patent/AU2984095A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU29840/95A 1994-07-11 1995-07-11 Novel combination product comprising capripramine and a neuroleptic Abandoned AU2984095A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR9408539A FR2722099B1 (en) 1994-07-11 1994-07-11 NEW COMBINATION PRODUCT COMPRISING CARPIPRAMINE AND A NEUROLEPTIC.
FR9408539 1994-07-11
PCT/FR1995/000925 WO1996001631A1 (en) 1994-07-11 1995-07-11 Novel combination product comprising capripramine and a neuroleptic

Publications (1)

Publication Number Publication Date
AU2984095A true AU2984095A (en) 1996-02-09

Family

ID=9465224

Family Applications (1)

Application Number Title Priority Date Filing Date
AU29840/95A Abandoned AU2984095A (en) 1994-07-11 1995-07-11 Novel combination product comprising capripramine and a neuroleptic

Country Status (3)

Country Link
AU (1) AU2984095A (en)
FR (1) FR2722099B1 (en)
WO (1) WO1996001631A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2802101B1 (en) * 1999-12-10 2003-02-28 Aventis Pharma Sa COMBINATION OF CYMEMAZINE AND AN ATYPICAL NEUROLEPTIC
WO2002053140A2 (en) * 2001-01-02 2002-07-11 Pharmacia & Upjohn Company New drug combinations of norepinehrine reuptake inhibitors and neuroleptic agents

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3505451A (en) * 1967-08-14 1970-04-07 Geigy Chem Corp Compositions and methods for alleviating schizophrenia employing one of haloperidol,trifluperidol or an acid addition salt thereof and one of desipramine,imipramine and an acid addition salt thereof
US4316897A (en) * 1980-09-10 1982-02-23 Hoffmann-La Roche Inc. Method of lowering serum prolactin

Also Published As

Publication number Publication date
WO1996001631A1 (en) 1996-01-25
FR2722099B1 (en) 1996-10-04
FR2722099A1 (en) 1996-01-12

Similar Documents

Publication Publication Date Title
AU684295B2 (en) Carboxamides
AU8865098A (en) A composition and a product containing the same
AU2716695A (en) Container
AU7037794A (en) Liquid-pumping container
AU2264695A (en) Containers
AU3077595A (en) Cleaning product and related packaging
AU1492095A (en) Container
AU4163096A (en) Polymer-saturated paper articles
AU2168995A (en) Container
AU5978694A (en) Container
AU1825795A (en) A fishing-float
AU3183095A (en) Prize-holding container
AU3621195A (en) A container
AU2984095A (en) Novel combination product comprising capripramine and a neuroleptic
AU2482195A (en) A label
AU2144195A (en) Container
AU2747595A (en) Container
AU1084895A (en) A valvulotome
AU3486895A (en) Toiletries product
AU1583295A (en) Waste product articles
AUPM819394A0 (en) Container
AU4270296A (en) Product labelling
AUPM638694A0 (en) A bookholder
AUPM610794A0 (en) A container
AUPM764094A0 (en) A container